E Arioglu

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes
    E Arioglu
    Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ann Intern Med 133:263-74. 2000
  2. ncbi request reprint Leptin-replacement therapy for lipodystrophy
    Elif Arioglu Oral
    Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892 1770, USA
    N Engl J Med 346:570-8. 2002
  3. ncbi request reprint Lipoatrophy revisited
    M L Reitman
    Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Building 10, Room 8N 250, 10 Center Drive, Bethesda, MD 20892 1770, USA
    Trends Endocrinol Metab 11:410-6. 2000
  4. ncbi request reprint Lipoatrophic-lipodystrophic syndromes: the spectrum of findings on MR imaging
    A PremKumar
    Department of Diagnostic Radiology, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bldg 10, Rm 1C660, 10 Center Dr MSC 1182, Bethesda, MD 20892 1182, USA
    AJR Am J Roentgenol 178:311-8. 2002
  5. ncbi request reprint A gene for congenital generalized lipodystrophy maps to human chromosome 9q34
    A Garg
    Department of Internal Medicine, and Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas, 75235, USA
    J Clin Endocrinol Metab 84:3390-4. 1999
  6. pmc Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C
    R A Speckman
    Division of Human Genetics, Departments of Genetics and Pediatrics, Washington University School of Medicine, St Louis, MO, USA
    Am J Hum Genet 66:1192-8. 2000

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes
    E Arioglu
    Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ann Intern Med 133:263-74. 2000
    ..Troglitazone promotes adipocyte differentiation in vitro and increases insulin sensitivity in vivo. Therefore, troglitazone may have therapeutic benefit in lipoatrophic diabetes...
  2. ncbi request reprint Leptin-replacement therapy for lipodystrophy
    Elif Arioglu Oral
    Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892 1770, USA
    N Engl J Med 346:570-8. 2002
    ..Since severe lipodystrophy is associated with leptin deficiency, insulin resistance, hypertriglyceridemia, and hepatic steatosis, we assessed whether leptin replacement would ameliorate this condition...
  3. ncbi request reprint Lipoatrophy revisited
    M L Reitman
    Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Building 10, Room 8N 250, 10 Center Drive, Bethesda, MD 20892 1770, USA
    Trends Endocrinol Metab 11:410-6. 2000
    ..Thiazolidinedione therapy improves metabolic control in lipoatrophic patients; the efficacy of leptin treatment is currently being investigated...
  4. ncbi request reprint Lipoatrophic-lipodystrophic syndromes: the spectrum of findings on MR imaging
    A PremKumar
    Department of Diagnostic Radiology, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bldg 10, Rm 1C660, 10 Center Dr MSC 1182, Bethesda, MD 20892 1182, USA
    AJR Am J Roentgenol 178:311-8. 2002
  5. ncbi request reprint A gene for congenital generalized lipodystrophy maps to human chromosome 9q34
    A Garg
    Department of Internal Medicine, and Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas, 75235, USA
    J Clin Endocrinol Metab 84:3390-4. 1999
    ..Identification of the CGL gene(s) will contribute to our understanding of the adipocyte differentiation and elucidation of the mechanisms of insulin resistance in disorders of adipose tissue...
  6. pmc Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C
    R A Speckman
    Division of Human Genetics, Departments of Genetics and Pediatrics, Washington University School of Medicine, St Louis, MO, USA
    Am J Hum Genet 66:1192-8. 2000
    ..The FPLD mutations R482Q and R482W occurred on different haplotypes, indicating that they are likely to have arisen more than once...